News Bungled Brexit move would trigger public health crisis, warn... Regulator could be crippled by staff exodus during relocation.
News Time running out for Brexit plans, warns pharma Prime Minister Theresa May is to unveil her updated plans for Brexit later today at a speech in Italy, and is expected to say both the UK and EU have a responsibility to strike a workable d
Brexit Pharma and biotech warn of Brexit threat to science recruitm... Government must strike science R&D deal with EU, says ABPI
News No EMA deal would ‘disable’ UK pharma, says Bell Failure to strike a Brexit deal allowing alignment with the European Medicines Agency would be ‘catastrophic’ for the UK life sciences sector.
News Strategy for post-Brexit life science sector unveiled Plan aims to solve long-standing issue of access to medicines
News Show ambition with UK life sciences plan, Novartis tells gov... Drugmaker concerned over access to new drugs
News Relief for AZ as Truqap hits the spot in prostate cancer After a disappointing result with Truqap in triple-negative breast cancer, AstraZeneca chalks up a win in prostate cancer
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
